Healthcare -
Biotechnology - NASDAQ - US
$ 5.59
1.64 %
$ 343 M
Market Cap
-3.14
P/E
GLUE - STOCK-BASED COMPENSATION
Stock-based Compensation GLUE - Monte Rosa Therapeutics, Inc.
16.7 M
LAST VALUE
79.04%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR